Lotus Eye Hospital and Institute Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Lotus Eye Hospital and Institute Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 14% in 3 years, but profit fell: ₹62 less profit per ₹100 of extra sales. Lower than 97% of Healthcare companies in India.
- Profit Cash Ratio: Over the last 3 years, every ₹100 of reported profit came with ₹305 of operating cash. Higher than 93% of Healthcare companies in India.
- Cash Locked Ratio: For every ₹100 of sales, ₹0 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹1 tied up three years earlier. Less money tied up than 87% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹305Over the last 3 years, every ₹100 of reported profit came with ₹305 of operating cash.
Higher than 93% of Healthcare companies in India.
Self-Funding Ratio
0.5×Over the last 3 years its own operating cash paid for 48% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 82% of Healthcare companies in India.
Cash Locked Ratio
₹0For every ₹100 of sales, ₹0 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹1 tied up three years earlier.
Less money tied up than 87% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 0/3Sales grew in 3 of the last 3 years; profit grew in 0 of 3.
Less steady than 83% of Healthcare companies in India.
Growth Efficiency Ratio
−₹62Sales grew 14% in 3 years, but profit fell: ₹62 less profit per ₹100 of extra sales.
Lower than 97% of Healthcare companies in India.
Asset Productivity Ratio
+14% / +31%In 3 years sales changed by +14% while total assets changed by +31%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
2.4×Debt due within a year is covered 2.4 times by its yearly operating cash.
Higher than 61% of Healthcare companies in India.
Cash Cushion Ratio
−5%Debt, after subtracting cash, equals 5% of its market value (net debt).
Lower than 66% of Healthcare companies in India.
Tangible Assets Ratio
100%Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 71% of Healthcare companies in India.
Tangible Net Worth Ratio
100%Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 73% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Lotus Eye Hospital and Institute Limited owes ₹0.27 for every ₹1 it owns. Net profit fell 89% in the year to Mar 2026, and shrank 73% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
1419.5Investors pay ₹1419.5 for every ₹1 of Lotus Eye Hospital and Institute Limited's yearly profit, higher than almost all Healthcare companies in India.
P/B ratio
3.93The share price is 3.93 times Lotus Eye Hospital and Institute Limited's book value per share, lower than 59% of Healthcare companies in India.
Market cap
₹236 CrThe total market value of all of Lotus Eye Hospital and Institute Limited's shares at today's price (share price × number of shares), smaller than 90% of Healthcare companies in India. PosiCap size class: Micro Cap.
Net worth (book value)
₹60 CrWhat Lotus Eye Hospital and Institute Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹28.92Net worth divided by the number of shares. The share price of ₹113.56 is 3.9 times this, which is the P/B above.
Return on equity (ROE)
0.3%Lotus Eye Hospital and Institute Limited earned 0.3% on its shareholders' money over the last year, lower than 92% of Healthcare companies in India.
Owes vs Owns
0.27×Lotus Eye Hospital and Institute Limited owes ₹0.27 for every ₹1 it owns (low), lower than 70% of Healthcare companies in India.
Dividend yield
NoneLotus Eye Hospital and Institute Limited does not currently pay a dividend.
Revenue growth
+8%Revenue rose 8% in the year to Mar 2026, and grew 5% a year on average over 3 years.
Profit growth
-89%Net profit fell 89% in the year to Mar 2026, and shrank 73% a year on average over 3 years.
Profit margin
0.2%Lotus Eye Hospital and Institute Limited keeps ₹0 of every ₹100 of revenue as net profit.
Cash quality
37.5×Cash from Lotus Eye Hospital and Institute Limited's business was 37.5× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
Not coveredLotus Eye Hospital and Institute Limited's operating profit did not cover its interest costs in the year to Mar 2026.
Cash vs debt
Net debtLotus Eye Hospital and Institute Limited had ₹12 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Lotus Eye Hospital and Institute Limited's P/E ratio?
Investors pay ₹1419.5 for every ₹1 of Lotus Eye Hospital and Institute Limited's yearly profit, higher than almost all Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Lotus Eye Hospital and Institute Limited: ₹236 Cr ÷ ₹60 Cr (31 Mar 2026) = 3.9.
What is Lotus Eye Hospital and Institute Limited's return on equity?
Lotus Eye Hospital and Institute Limited earned 0.3% on its shareholders' money over the last year, lower than 92% of Healthcare companies in India.
How much does Lotus Eye Hospital and Institute Limited owe compared with what it owns?
Lotus Eye Hospital and Institute Limited owes ₹0.27 for every ₹1 it owns (low), lower than 70% of Healthcare companies in India.
Does Lotus Eye Hospital and Institute Limited pay a dividend?
No. Lotus Eye Hospital and Institute Limited does not currently pay a dividend.
Is Lotus Eye Hospital and Institute Limited's revenue growing?
Revenue rose 8% in the year to Mar 2026, and grew 5% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.